Assignee
GEMVAX & KAEL CO LTD
KR·41 granted patents·3 pending applications·160 citations·filing 2013–2023
Top patents by PatentIndex Score
44 records- 0198US11369665B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2020·Granted Jun 28, 2022·4 cites·9 claims
- 0296US9902945B2Cell penetrating peptide, conjugate comprising same, and composition comprising conjugateGEMVAX & KAEL CO LTD·Filed 2013·Granted Feb 27, 2018·12 cites·7 claims
- 0395US10960056B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2018·Granted Mar 30, 2021·4 cites·9 claims
- 0495US10039811B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2016·Granted Aug 7, 2018·10 cites·9 claims
- 0595US9572858B2Composition for treating and preventing benign prostatic hyperplasiaGEMVAX & KAEL CO LTD·Filed 2016·Granted Feb 21, 2017·20 cites·17 claims
- 0695US9540419B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2013·Granted Jan 10, 2017·20 cites·8 claims
- 0793US9527888B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2013·Granted Dec 27, 2016·11 cites·3 claims
- 0892US10888606B2Anti-inflammatory peptides and compositions comprising the sameGEMVAX & KAEL CO LTD·Filed 2018·Granted Jan 12, 2021·2 cites·3 claims
- 0992US9572900B2Cell penetrating peptide, conjugate comprising same, and composition comprising conjugateGEMVAX & KAEL CO LTD·Filed 2013·Granted Feb 21, 2017·12 cites·17 claims
- 1091US12168039B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2023·Granted Dec 17, 2024·0 cites·8 claims
- 1191US12156902B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2023·Granted Dec 3, 2024·0 cites·8 claims
- 1290US11622998B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2020·Granted Apr 11, 2023·1 cites·7 claims
- 1389US12171812B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2023·Granted Dec 24, 2024·0 cites·4 claims
- 1489US9937240B2Peptide having fibrosis inhibitory activity and composition containing sameGEMVAX & KAEL CO LTD·Filed 2015·Granted Apr 10, 2018·7 cites·16 claims
- 1589US9757473B2Cell-penetrating peptide and conjugate comprising sameGEMVAX & KAEL CO LTD·Filed 2014·Granted Sep 12, 2017·12 cites·12 claims
- 1689US9631184B2Cell penetrating peptide, conjugate comprising same, and composition comprising conjugateGEMVAX & KAEL CO LTD·Filed 2013·Granted Apr 25, 2017·11 cites·22 claims
- 1788US11773381B2Cell penetrating peptide, conjugate comprising same, and composition comprising conjugateGEMVAX & KAEL CO LTD·Filed 2020·Granted Oct 3, 2023·1 cites·21 claims
- 1887US10206981B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2016·Granted Feb 19, 2019·3 cites·12 claims
- 1985US11857607B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2022·Granted Jan 2, 2024·0 cites·8 claims
- 2085US10034922B2Peptide having angiogenesis inhibitory activity and composition containing sameGEMVAX & KAEL CO LTD·Filed 2014·Granted Jul 31, 2018·7 cites·16 claims
- 2184US10822595B2Cell penetrating peptide, conjugate comprising same, and composition comprising conjugateGEMVAX & KAEL CO LTD·Filed 2018·Granted Nov 3, 2020·1 cites·18 claims
- 2284US10676507B2Peptide and composition containing the same for anti-inflammation, anti-fibrosis, wound healing, and anticancer treatmentGEMVAX & KAEL CO LTD·Filed 2016·Granted Jun 9, 2020·4 cites·16 claims
- 2383US11098294B2Anti-inflammatory peptides and composition comprising sameGEMVAX & KAEL CO LTD·Filed 2020·Granted Aug 24, 2021·1 cites·5 claims
- 2483US2024181090A1Cell penetrating peptide, conjugate comprising same, and composition comprising conjugateGEMVAX & KAEL CO LTD·Filed 2023·Application pending·0 cites
- 2582US10967000B2Cell-penetrating peptide, conjugate comprising same and composition comprising sameGEMVAX & KAEL CO LTD·Filed 2013·Granted Apr 6, 2021·2 cites·16 claims
- 2682US10245327B2Cell penetrating peptide, conjugate comprising same, and composition comprising conjugateGEMVAX & KAEL CO LTD·Filed 2016·Granted Apr 2, 2019·2 cites·34 claims
- 2778US11905536B2Anti-inflammatory peptides and composition comprising the sameGEMVAX & KAEL CO LTD·Filed 2021·Granted Feb 20, 2024·0 cites·6 claims
- 2878US10383926B2Biological markers useful in cancer immunotherapyGEMVAX & KAEL CO LTD·Filed 2014·Granted Aug 20, 2019·3 cites·7 claims
- 2978US9907837B2Composition for preventing or treating cachexiaGEMVAX & KAEL CO LTD·Filed 2013·Granted Mar 6, 2018·2 cites·16 claims
- 3078US9907838B2Composition and methods for treating ischemic damageGEMVAX & KAEL CO LTD·Filed 2014·Granted Mar 6, 2018·3 cites·16 claims
- 3178US9730984B2Composition for preventing or treating rheumatoid arthritisGEMVAX & KAEL CO LTD·Filed 2013·Granted Aug 15, 2017·2 cites·16 claims
- 3275US11844845B2Cell penetrating peptide, conjugate comprising same, and composition comprising conjugateGEMVAX & KAEL CO LTD·Filed 2019·Granted Dec 19, 2023·0 cites·8 claims
- 3374US11077163B2Peptide for treating ocular diseases and composition for treating ocular diseases comprising sameGEMVAX & KAEL CO LTD·Filed 2019·Granted Aug 3, 2021·0 cites·12 claims
- 3473US10463708B2Peptide for treating ocular diseases and composition for treating ocular diseases comprising sameGEMVAX & KAEL CO LTD·Filed 2015·Granted Nov 5, 2019·1 cites·15 claims
- 3566US11058744B2Composition for treating prostate cancerGEMVAX & KAEL CO LTD·Filed 2014·Granted Jul 13, 2021·0 cites·16 claims
- 3665US10662223B2Composition for organ, tissue, or cell transplantation, kit, and transplantation methodGEMVAX & KAEL CO LTD·Filed 2014·Granted May 26, 2020·0 cites·14 claims
- 3762US9844584B2Composition for preventing or treating sepsisGEMVAX & KAEL CO LTD·Filed 2013·Granted Dec 19, 2017·0 cites·12 claims
- 3857USD1009297SVial bottle protector caseGEMVAX & KAEL CO LTD·Filed 2021·Granted Dec 26, 2023·2 cites·1 claims
- 3955US11015179B2Peptide having anti-viral effect and composition containing sameGEMVAX & KAEL CO LTD·Filed 2016·Granted May 25, 2021·0 cites·6 claims
- 4055US10561703B2Method of modulating sex hormone levels using a sex hormone secretion modulatorGEMVAX & KAEL CO LTD·Filed 2014·Granted Feb 18, 2020·0 cites·20 claims
- 4151US2018207241A1Peptide having fibrosis inhibitory activity and composition containing sameGEMVAX & KAEL CO LTD·Filed 2018·Application pending·0 cites
- 4250US10835582B2Peptide for preventing hearing loss, and composition comprising sameGEMVAX & KAEL CO LTD·Filed 2016·Granted Nov 17, 2020·0 cites·17 claims
- 4341US10898540B2Peptide having effects of increasing telomerase activity and extending telomere, and composition containing sameGEMVAX & KAEL CO LTD·Filed 2017·Granted Jan 26, 2021·0 cites·6 claims
- 4435US2018318383A1Peptide having neuronal loss prevention and regeneration effects, and composition containing sameGEMVAX & KAEL CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GEMVAX & KAEL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →